The Effects of Folic Acid on Sudanese Women With Polycystic Ovary Syndrome
An open clinical trial
Polycystic Ovary Syndrome
DRUG: Folic Acid
pregnancy rates, Pregnancy rates will be compared in the treatment group and control group, 3 months|Ovulatory pattern improvements, Ovulatory pattern will be assessed based on the history of the PCOS patients, the patients whom were having baseline oligomenorrhea or amenorrhea will be re-assessed for resuming regular cycles defined as periods lasting 22 - 35 days. this pattern improvement will be compared in the treatment group and control group using questionnaire, 3 months|Clinical signs of hyperandrogenemia, Hirsutism will be used as a sign of hyperandrogenemia, Patients will be provided with modified Ferriman -Gallwey (mFG) images to self-rate hair growth in each of the 9 body areas (upper lip, chin, chest, upper and lower back, upper and lower abdomen, thighs, and upper arms). For each site, a score on a scale of 0 to 4 was recorded. A total score of 8 or greater is defined as clinical evidence of hirsutism; scores from 8 to 15 are considered mild hirsutism; scores from16 to 25 are considered moderate; and scores from 26 to 36 are considered severe hirsutism. The baseline and after 3 months hirsutism compared in the treatment group and control group, 3 months
Plasma level of testosterone, Plasma level of testosterone will be compared in the treatment group and control group, 3 months|Plasma level of insulin, Plasma level of insulin will be compared in the treatment group and control group, 3 months|Plasma level of follicle-stimulating hormone (FSH), Plasma level of follicle-stimulating hormone will be compared in the treatment group and control group, 3 months|Plasma level of luteinizing hormone (LH), Plasma level of luteinizing hormone will be compared in the treatment group and control group, 3 months
Lipid profile, Lipid profile will be compared in the treatment group and control group, 3 months|Plasma level of random glucose, Plasma level of random glucose will be compared in the treatment group and control group, 3 months|Plasma level of folate, Plasma level of folate will be compared in the treatment group and control group, 3 months|Plasma level of homocysteine (Hcy), Plasma level of homocysteine (Hcy) will be compared in the treatment group and control group, 3 months|Plasma level of hemoglobin (Hb), Plasma level of hemoglobin (Hb) will be compared in the treatment group and control group, 3 months|Plasma level of C-reactive protein (CRP), Plasma level of C-reactive protein (CRP) will be compared in the treatment group and control group, 3 months
The patients with PCOS will be recruited to receive folic acid (45 patients) and equal number will receive no folic acid